In aspirin-exacerbated respiratory disease, which statement is true?

Consult the Mehlman High Yield Exam for strategic exam preparation and test mastery. Access multiple choice questions with detailed explanations to enhance your study sessions. Get exam-ready now!

Multiple Choice

In aspirin-exacerbated respiratory disease, which statement is true?

Explanation:
In aspirin-exacerbated respiratory disease, the issue is cross-reactivity to NSAIDs that inhibit COX-1, which shifts arachidonic acid metabolism toward leukotrienes and triggers bronchospasm and nasal symptoms in sensitive individuals. Because many non-aspirin NSAIDs also block COX-1, they can precipitate reactions, not just aspirin itself. Acetaminophen generally does not inhibit COX-1 in the airways, so it is usually tolerated. NSAIDs never trigger reactions and the idea that only aspirin triggers the response are not accurate.

In aspirin-exacerbated respiratory disease, the issue is cross-reactivity to NSAIDs that inhibit COX-1, which shifts arachidonic acid metabolism toward leukotrienes and triggers bronchospasm and nasal symptoms in sensitive individuals. Because many non-aspirin NSAIDs also block COX-1, they can precipitate reactions, not just aspirin itself. Acetaminophen generally does not inhibit COX-1 in the airways, so it is usually tolerated. NSAIDs never trigger reactions and the idea that only aspirin triggers the response are not accurate.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy